Aktuelles & Neues von uns und unseren Kunden
Ym Biosciences Reports Fiscal Year End 2009 Operational and Financial Results
25. September 2009On Friday September 25, 2009, 7:00 am EDT
YM Biosciences Reports Nimotuzumab Approved for Marketing in Mexico
17. September 2009YM enrolls first patients in multinational randomized, double-blind brain metastases trial
Das US-Finanzministerium erteilt YM BioSciences USA die Genehmigung das klinische Programm für Nimotuzumab auszuweiten.
10. August 2009Montag, 10. August 2009, 7 Uhr (EDT)
Ym Biosciences' Subsidiary Resolves Proposed Arbitration With Oncoscience Ag
29. Juni 2009On Monday June 29, 2009, 7:00 am EDT
Ym Biosciences Reports Daiichi-Sankyo Enrolls First Patients in Phase II, First-Line Lung Cancer Trial With Nimotuzumab
24. Juni 2009On Tuesday June 23, 2009, 11:48 am EDT